COMMON VARIABLE IMMUNODEFICIENCY (CVID): CASE REPORT AND REVIEW OF THE LITERATURE

REFERENCES

• BoyEe JM, BuckEey RH. PopuEation preva[ence of diagnosed pri-mary immunodeficiency diseases in the United States.] Clin Immunol. 2007;27(5):497–502.
   Web of Science ®Google Scholar
• ConEey ME, Notarange[o LD, Etzioni A. Diagnostic Criteria for Primary Immunodeficiencies. Representing PAGID (Pan-Ameri-can Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93(3):190–7.
   Web of Science ®Google Scholar
• DanieEs JA, Lederman HM, Maitra A, Montgomery EA. Gastroin-testinaE tract pathoEogy in patients with common variabEe im-munodeficiency (CVID): a clinicopathoEogic study and review. AmJ Surg Pathol. 2007;31(12):1800–12.
   Web of Science ®Google Scholar
• Primary immunodeficiency diseases. Report of a WHO scien-tific group. Clin Exp Immunol. 1997;109(SuppE 1):1–28.
   Google Scholar
• Fernández-Ruiz M, Guerra-Va[es J-M, Francisco-Javier C-F, Yo-Eanda R-G, MigueE-AngeE M-G, Cristina G-C, et al Fever of un-known origin in a patient with common variabEe immunodeficiency associated with multisystemic granulomatous disease. Intern Med. 2007;46(15):1197–202.
   PubMed Web of Science ®Google Scholar
• Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008112(2):277–86.
   Google Scholar
• Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Ago-stini C, et al. Long-Term Follow-Up and Outcome of a Large Cohort of Patients with Common Variable Immunodeficiency./ Clin lmmunol. 2007;27(3):308–16.
   Web of Science ®Google Scholar
• Lopes-da-Silva S, Rizzo LV. Autoimmunity in Common Variable Immunodeficiency./ Clin Immunol. 2008;28(Suppl 1):S46–S55.
   Web of Science ®Google Scholar
• Oksenhendler E, Gerard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, et al. Infections in 252 patients with common vari-able immunodeficiency. Clin Infect Dis. 2008;46(10)1547–54.
   PubMed Web of Science ®Google Scholar
• Castigli E, Geha RS. Molecular basis of common variable im-munodeficiency. /Allergy Clin Immunol. 2006;117(4):740–6.
   PubMed Web of Science ®Google Scholar
• Knight AK, Cunningham-Rundles C. Inflammatory and autoim-mune complications of common variable immune deficiency. Autoimmun Rev. 2006;5(2):156–9.
   PubMed Web of Science ®Google Scholar
• Cunningham-Rundles C, Bodian C. Common Variable Immu-nodeficiency: Clinical and Immunological Features of 248 Pa-tients. Clin lmmunol. 1999;92(1):34–48.
   PubMed Web of Science ®Google Scholar
• Wood P, Stanworth S, Burton J, Jones A, Peckham DG, Green T, et al. Recognition, clinical diagnosis and management of pa-tients with primary antibody deficiencies: a systematic review. Clin Exp Immunol. 2007;149(3):410–23.
   PubMed Web of Science ®Google Scholar
• Kopecky O, Lukesove S. Genetic defects in common variable immunodeficiency. Intl lmmunogenet. 2007;34(4):225–9.
   Web of Science ®Google Scholar
• Salzer U, Neumann C, Thiel J, Woellner C, Pan-Hammarstrom Q, Lougaris V, et al. Screening of functional and positional can-didate genes in families with common variable immunodefi-ciency. BMC Immunol. 2008;9(1):3–11.
   Web of Science ®Google Scholar
• Bacchelli C, Buckridge S, Thrasher AJ, Gaspar HB. Translational Mini-Review Series on Immunodeficiency: Molecular defects in common variable immunodeficiency. Clinical and Experimental Immunology. 2007;149(3):401–9.
   Web of Science ®Google Scholar
• Edgar JDM. T cell immunodeficiency. J Clin Pathol. 2008;61(9):988–93.
   PubMed Web of Science ®Google Scholar
• Hammarstrom L, Vorechovsky I, Webster D. Selective IgA de-ficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol. 2000;120(2):225–31.
   PubMed Web of Science ®Google Scholar
• Bloom KA, Chung D, Cunningham-Rundles C. Osteoarticular infectious complications in patients with primary immunode-ficiencies. Curr Opin Rheumatol. 2008;20(4):480–5.
   Web of Science ®Google Scholar
• Mechanic Li, Dikman S, Cunningham-Rundles C. Granuloma-tous disease in common variable immunodeficiency. Ann Intern Med. 1997;127(8 Pt 1):613–7.
   PubMed Web of Science ®Google Scholar
• Giannouli S, Anagnostou D, Soliotis F, Voulgarelis M. Autoim-mune manifestations in common variable immunodeficiency. Clin Rheumatol. 2004;23(5):449–52.
   Web of Science ®Google Scholar
• Malphettes M, Oksenhendler E, Galicier L, Fieschi C. Maladie granulomateuse au cours du deficit immunitaire commun vari-able. Rev Med Interne. 2008;29(1):28–32.
   Web of Science ®Google Scholar
• Chua I, Quinti I, Grimbacher B. Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics. Curr Opin Hematol. 2008;15(4):368–74.
   Web of Science ®Google Scholar
• Vorechovsky I, Scott D, Haeney MR, Webster DAB. Chromo-somal radiosensitivity in common variable immune deficiency. Mutat Res. 1993;290(2):255–64.
   Web of Science ®Google Scholar
• Gardulf A, Borte M, Ochs HD, Nicolay U, Group tVCS. Prognos-tic factors for health-related quality of life in adults and chil-dren with primary antibody deficiencies receiving SCIG home therapy. Clin Immunol. 2008126(1):81–8.
   Google Scholar
• Gardulf A, Nicolay U, Asensio O, Bernatowska E, Bock A, Carvalho BC, et al. Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary im-munodeficiencies-a prospective, multi-national study. J Clin Immunol. 2006;26(2)177–85.
   PubMed Web of Science ®Google Scholar
• Latiff AHA, Kerr MA. The clinical significance of immunoglobu-lin A deficiency. Ann Clin Biochem. 2007;44(2):131–9.
   Web of Science ®Google Scholar
• Schaffer FM. Clinical assessment and management of abnor-mal IgA levels. Ann Allergy Asthma Immunol. 2008;100(3):280–2.
   Web of Science ®Google Scholar
• Primary Immune Deficiency Diseases in America. The second national survey of patients (2002). Available at www.primary-immuneorg/survey_research/surveyshtm.
   Google Scholar
• Bagdasarian A, Tonetta S, Harel W, Mamidi R, Uemura Y. IVIG Adverse Reactions: Potential Role of Cytokines and Vasoactive Substances. Vox Sang. 1998;74(2):74–82.
   Web of Science ®Google Scholar
• Eijkhout HW, van den Broeck PJ, van der Meer JWM. Substitu-tion therapy in immunodeficient patients with anti-IgA anti-bodies or severe adverse reactions to previous immunoglobulin therapy. Neth J Med. 2003;61(6):213–7.
   PubMed Web of Science ®Google Scholar
• Quinti I, Soresina A, Agostini C, Spadaro G, Matucci A, Sfika I, et al. Prospective Study on CVID Patients with Adverse Reactions to Intravenous or Subcutaneous IgG Administration.] Clin Im-munol. 2008;28(3):263–7.
   Web of Science ®Google Scholar
• El-Shanawany TM, Williams PE, Jolles S. Response of refrac-tory ITP in a patient with common variable immunodefi-ciency (CVID) to treatment with rituximab. J Clin Pathol. 2007: jcp.2006.041426.
   Google Scholar
• Carbone J, Escudero A, Mayayo M, Ballesteros M, Perez-Corral A, Sanchez-Ramon S, et al. Partial Response to Anti-CD20 Monoclonal Antibody Treatment of Severe Immune Thrombo-cytopenic Purpura in a Patient with Common Variable Immunodeficiency. Ann N Y Acad Sci. 2005;1051:666–71.
   PubMed Web of Science ®Google Scholar